Gainers
- Stealth BioTherapeutics MITO stock rose 3.59% to $1.44 during Thursday's after-market session. The market value of their outstanding shares is at $82.9 million.
- Advaxis ADXS shares rose 2.8% to $0.54. The company's market cap stands at $78.3 million. The company's, Q3 earnings came out 4 days ago.
- Beyond Air XAIR stock increased by 2.16% to $12.29. The market value of their outstanding shares is at $294.3 million.
- Teligent TLGT shares rose 1.93% to $0.39. The market value of their outstanding shares is at $36.1 million.
- InVivo Therapeutics Hldg NVIV shares moved upwards by 1.74% to $0.62. The market value of their outstanding shares is at $21.2 million.
- Calithera Biosciences CALA shares increased by 1.46% to $2.08. The company's market cap stands at $154.1 million.
Losers
- Champions Oncology CSBR shares decreased by 6.0% to $10.03 during Thursday's after-market session. The market value of their outstanding shares is at $134.6 million. The company's, Q1 earnings came out 3 days ago.
- Gritstone Bio GRTS shares decreased by 5.25% to $12.83. Trading volume for this security closed at 175.0K, accounting for 24.13% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $634.4 million.
- Checkpoint Therapeutics CKPT stock decreased by 4.9% to $3.11. The company's market cap stands at $257.3 million.
- Indaptus Therapeutics INDP shares decreased by 4.41% to $11.07. The company's market cap stands at $59.8 million.
- Pieris Pharmaceuticals PIRS stock declined by 4.0% to $5.53. The company's market cap stands at $368.9 million.
- ClearPoint Neuro CLPT stock decreased by 3.55% to $18.25. The company's market cap stands at $408.1 million.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in